The drug Hypoxen: a new inhibitor of mitochondrial respiration and dehydrogenases
Lab research · 2010
- What was studied
- Isolated rat liver mitochondria
- Main finding
- Hypoxen reduced phosphorylating and uncoupled respiration, with substrate-dependent concentration thresholds. Malate, glutamate and succinate dehydrogenase activities decreased. This qualifies the claim that it uniformly increases mitochondrial respiration.
Study data at a glance
- Participants or experimental model
- Isolated rat liver mitochondria
- Reported results
- Hypoxen reduced phosphorylating and uncoupled respiration, with substrate-dependent concentration thresholds. Malate, glutamate and succinate dehydrogenase activities decreased. This qualifies the claim that it uniformly increases mitochondrial respiration.
Study limitations and source details
Study limitations
- Isolated organelles and experimental concentrations do not establish effects of oral use in humans.
- The translation and Russian paper are the same experiment.
Source details
Journal article
Indexed or publisher abstract reviewed; full methods and risk of bias not appraised.
Abstract reviewed
Sources checked
Citation
E. A. Kosenko, M. B. Abramova, N. I. Venediktova, I. I. Popova, Yu. G. Kaminskii. The drug Hypoxen: a new inhibitor of mitochondrial respiration and dehydrogenases Izv Akad Nauk Ser Biol. (4):411–416; English translation Biology Bulletin 37:346–350
Study source ↗ · DOI 10.1134/S1062359010040035 · Bibliography entry · Link to this summary